Feedback
Make this your Home
News Markets Mutual Funds IPO Commodities Wealth Portfolio Messages Videos Mail CNBC-TV18
CNBC-TV18 Matrix SENSEX 17180.18 158.33 NIFTY 5103.55 51.10
 

Arch Pharmalabs Half Yearly Results, Arch Pharmalabs Financial Statement & Accounts

Arch Pharmalabs

BSE: 524729  |  NSE: N.A  |  ISIN: INE182F01017  |  Pharmaceuticals

Print/Copy to Excel :
« Previous Years  

Half Yearly Results of Arch Pharmalabs

------------------- in Rs. Cr. -------------------
Sep '03 Mar '04 Sep '04 Mar '05 Sep '05
6 mths 6 mths 6 mths 6 mths 6 mths
Sales Turnover 21.90 74.56 73.63 82.05 103.25
Other Income 0.11 0.21 0.07 0.19 0.24
Total Income 22.00 74.77 73.70 82.24 103.49
Total Expenses 17.52 61.83 59.89 67.27 82.87
Operating Profit 4.38 12.73 13.74 14.78 20.38
Profit On Sale Of Assets -- -- -- -- --
Profit On Sale Of Investments -- -- -- -- --
Gain/Loss On Foreign Exchange -- -- -- -- --
VRS Adjustment -- -- -- -- --
Other Extraordinary Income/Expenses -- -- -- -- --
Total Extraordinary Income/Expenses -- -- -- -- --
Tax On Extraordinary Items -- -- -- -- --
Net Extra Ordinary Income/Expenses -- -- -- -- --
Gross Profit 4.49 12.94 13.81 14.97 20.62
Interest 1.21 4.97 3.40 5.87 6.50
PBDT 3.27 7.97 10.41 9.11 14.12
Depreciation 0.49 0.61 1.24 2.08 4.09
Depreciation On Revaluation Of Assets -- -- -- -- --
PBT 2.78 7.36 9.17 7.03 10.03
Tax -- 1.20 2.85 2.15 2.75
Net Profit 2.78 6.16 6.32 4.88 7.28
Prior Year Income/Expenses -- -- -- -- --
Depreciation for Previous Years Written Back/ Provided -- -- -- -- --
Dividend -- -- -- -- --
Dividend Tax -- -- -- -- --
Dividend (%) -- -- -- -- --
Earnings Per Share(Rs) 5.31 7.05 6.79 3.70 5.32
Book Value(Rs) -- -- -- -- --
Equity 5.23 8.73 9.30 13.17 13.69
Reserves -- -- -- -- --
Face Value(Rs) 10.00 10.00 10.00 10.00 10.00
Source : Religare Technova
Explore Arch Pharmalabs connections